Dapagliflozin update

New Update: Dapagliflozin is now approved for treatment of heart failure in patients with reduced ejection fraction(HFrEF) The approval follows positive results from the landmark Phase III DAPA-HF trial.

3 Likes

LikeAnswersShare

Yes it is now well advocated in cases of diabetic as well as nondiabetic heart failure with low ejection fraction

Yes sir
0

Thanks for sharing this informative post

Welcome dr
0

Thank u sir for the info

Welcome dr
0

Thanks for update

Welcum dr
0

Informative

Welcum dr
0

Nice update

Welcum dr
1

Informative

Welcum
0